Response to Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136.

Authors :: Herring, Roselle A.
Shojaee-Moradie, Fariba
Garesse, Robert
Stevenage, Mary
Jackson, Nicola
Fielding, Barbara A.
Mendis, Agampodi
Johnsen, Sigurd
Umpleby, A. Margot
Davies, Melanie
Russell-Jones, David L.
Source :: Diabetes Care. 3/1/2021, Vol. 44 Issue 3, pe61-e61. 1p.
Publication Year :: 2021

Subjects :: *TYPE 1 diabetes
*DAPAGLIFLOZIN
*SODIUM-glucose cotransporter 2 inhibitors
*INSULIN
*KETOACIDOSIS
*ATLANTIC herring

Full Text Access

Tools